Results 71 to 80 of about 22,074 (161)
Respiratory infections and chronic lung disease are major contributors to morbidity in children. Aztreonam lysine for inhalation (AZLI) delivers high local antibiotic concentrations while limiting systemic exposure; however, its safety in younger ...
Valmir N. Rastely-Junior +2 more
doaj +1 more source
A 65-year-old man without identifiable risk factors for multidrug-resistant pathogens was admitted with peritonitis, isolating NDM-producing Escherichia coli from a rectal swab and intraoperative samples.
Claudia Fabrizio +13 more
doaj +1 more source
There is an urgent need for additional therapeutic solutions to treat serious bacterial infections caused by metallo-β-lactamase (MBL)-producing Klebsiella pneumoniae.
Arunkumar Karunanidhi +10 more
doaj +1 more source
The enzymes responsible for the synthesis of the peptidoglycan (PG) layer constitute a fundamental target for a large group of antibiotics. The family of β-lactam antibiotics inhibits the DD-transpeptidase (TPase) activity of the penicillin binding ...
Alejandro Montón Silva +6 more
doaj +1 more source
ObjectiveThis study aims to investigate the synergistic effects and biofilm inhibition mechanisms of ceftazidime-avibactam (CZA) combined with aztreonam (ATM) against carbapenem-resistant Klebsiella pneumonia (CRKP) commonly found in the local clinical ...
Guangfen Wang +8 more
doaj +1 more source
Aztreonam belongs to the monobactam group of naturally occurring antibiotic compounds characterized by a monocycling ring structure. Aztreonam is the first monobactam that has been approved for use in pediatric medicine by US FDA in the year 1998.
Seema, Kapoor, Geeta, Gathwala
openaire +1 more source
Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
Tan X, Kim HS, Baugh K, et al. Infect Drug Resist.2021;14:125–142. Page 134, left column, second paragraph, fourth sentence from the bottom, the text “Generally, all four tetracyclines have higher tissue concentrations than ...
Tan X +8 more
doaj
BACKGROUND: Aztreonam-avibactam is approved in the European Union for treatment of hospital/ventilator acquired bacterial pneumonia, complicated intraabdominal infection, complicated urinary tract infection and infections where treatment options are ...
Mark Estabrook +4 more
doaj +1 more source
NDM-producing carbapenem-resistant bacterial infections became a challenge for clinicians. Combination therapy of aztreonam and ceftazidime-avibactam is a prudent choice for these infections.
Salman Khan +8 more
doaj +1 more source
Qimei Wei,1,* Rong Cong,1,* Chang Shen,2 Chen Chen,1 Zheng Cao,1 Chanjun Ren,3 Tingting Liu2 1Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People’s Republic of China; 2Department of Cardiac Critical Care ...
Wei Q +6 more
doaj

